Layer 1

What's next for the Parkinson's MUR?

(Left to right): North-west London LPF lead Stephanie Bancroft; clinical editor Kristoffer Stewart; pharmacist Christopher Glass
(Left to right): North-west London LPF lead Stephanie Bancroft; clinical editor Kristoffer Stewart; pharmacist Christopher Glass

C+D spoke to Stephanie Bancroft to discuss the progress of Parkinson's-specific medicines use review (MUR).

Ms Bancroft, community pharmacist and Royal Pharmaceutical Society local pharmacy forum lead for north-west London, has been working on a joint project with Parkinson's UK to introduce a Parkinson's disease-specific MUR.

The MUR toolkit was originally tested on 32 Parkinson's patients in 2016, before being rolled out to 29 pharmacists "from all over the UK", Ms Bancroft told C+D.

Watch the video to find out:

  • How the Parkinson's-specific MUR was created
  • The accreditation pharmacists undertake to enable them to deliver the service
  • The difference it made to one pharmacist, Christopher Glass, in his ability to perform an effective MUR
  • How Mr Glass has been working with his local GP to help them review patients with Parkinson's disease
  • The next steps for this project, including working with care homes and practice pharmacists.

View the full video below:

2 Comments

Valentine Trodd, Community pharmacist

More MURs? No thanks...

James Mac, Community pharmacist

Its on shaky ground. It's a bit like the ED service- a total flop! Nobody came.

Job of the week

Accreditation and Recognition Panel member positions
Home Based
On application


Have your say

Should the pandemic delivery service have been extended beyond July 31?